GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ovctek China Inc (SZSE:300595) » Definitions » Capex-to-Revenue

Ovctek China (SZSE:300595) Capex-to-Revenue : 0.14 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ovctek China Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Ovctek China's Capital Expenditure for the three months ended in Mar. 2024 was ¥-64.21 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥464.53 Mil.

Hence, Ovctek China's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.14.


Ovctek China Capex-to-Revenue Historical Data

The historical data trend for Ovctek China's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovctek China Capex-to-Revenue Chart

Ovctek China Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.11 0.11 0.09 0.11

Ovctek China Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.14 0.12 0.11 0.14

Competitive Comparison of Ovctek China's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, Ovctek China's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ovctek China's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ovctek China's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ovctek China's Capex-to-Revenue falls into.



Ovctek China Capex-to-Revenue Calculation

Ovctek China's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-197.933) / 1737.168
=0.11

Ovctek China's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-64.205) / 464.529
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ovctek China  (SZSE:300595) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Ovctek China Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ovctek China's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ovctek China (SZSE:300595) Business Description

Traded in Other Exchanges
N/A
Address
No. 4899 Wangjiang West Road, High-tech Zone, Anhui Province, Hefei, CHN, 230088
Ovctek China Inc is a China-based company engaged in the research and development, production, and sales of rigid gas permeable contact lens products. Its products include Hard Mirror, Mirror Teshu family, High-end ophthalmic products, and Security products. The company-owned trademarks are DreamVision, DreamDawei, Ri Dawei, Hua Cone, Jing Teshu, openvision, and Mengshiqing among others.
Executives
Tao Yue Qun Directors, executives
Directors, executives
Yin Yin Director

Ovctek China (SZSE:300595) Headlines

No Headlines